Implantation failure Clinical Trials

9 recruitingLast updated: June 18, 2026

There are 9 actively recruiting implantation failure clinical trials across 6 countries. Studies span Not Applicable, Early Phase 1, Phase 3. Top locations include Aarhus, Denmark, Amiens, Picardie, France, Colombo, Sri Lanka. Updated daily from ClinicalTrials.gov.


Implantation failure Trials at a Glance

9 actively recruiting trials for implantation failure are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Aarhus, Amiens, and Colombo. Lead sponsors running implantation failure studies include Assistance Publique - Hôpitaux de Paris, Centre Hospitalier Universitaire, Amiens, and Aalborg University Hospital.

Browse implantation failure trials by phase

Treatments under study

About Implantation failure Clinical Trials

Looking for clinical trials for Implantation failure? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Implantation failure trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Implantation failure clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage

Recurrent miscarriageImmune SystemRepeated Embryo Implantation Failure
Centre Hospitalier Universitaire, Amiens150 enrolled1 locationNCT05648136
Recruiting
Not Applicable

Effect of Acupuncture on IVF Pregnancy Outcomes for Women With RIF

Repeated Implantation Failure
Huazhong University of Science and Technology771 enrolled1 locationNCT04533295
Recruiting

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

Recurrent miscarriageRecurrent implantation failureMannose binding lectin deficiency+4 more
Aalborg University Hospital500 enrolled1 locationNCT05169541
Recruiting
Early Phase 1

Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

Recurrent implantation failureAsherman SyndromeAtrophic Endometrium
Hugh Taylor90 enrolled1 locationNCT05343572
Recruiting
Not Applicable

Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT)

Advanced ageFemale InfertilityMitochondria+2 more
Sunkaky Medical Cooperation20 enrolled1 locationNCT07066267
Recruiting
Not Applicable

Comparing FET Guided by ERA Vs Standard Timing in Patients with Recurrent Implantation Failure

Recurrent implantation failureInfertility
The University of Hong Kong734 enrolled1 locationNCT06762626
Recruiting
Not Applicable

Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure

Recurrent implantation failure
Universitaire Ziekenhuizen KU Leuven100 enrolled1 locationNCT03900780
Recruiting
Not Applicable

Application of Platelet-rich Plasma (PRP) in Reproductive Medicine

Poor ovarian responsePremature Ovarian InsufficiencyIntrauterine Adhesion+2 more
The Fourth Affiliated Hospital of Zhejiang University School of Medicine300 enrolled1 locationNCT06645379
Recruiting
Phase 3

Certolizumab in Recurrent Implantation Failure (RIF)

Recurrent Unexplained Implantation Failure
Assistance Publique - Hôpitaux de Paris161 enrolled1 locationNCT05930613